Tower Research Capital LLC (TRC) - ETERNA THERAPEUTICS INC ownership

ETERNA THERAPEUTICS INC's ticker is and the CUSIP is 114082209. A total of 20 filers reported holding ETERNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ETERNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$9,468
-3.4%
5,174
+26.7%
0.00%
Q1 2024$9,799
+23.8%
4,083
-7.4%
0.00%
Q4 2023$7,914
-21.2%
4,409
-4.2%
0.00%
Q3 2023$10,037
-11.7%
4,604
-8.5%
0.00%
Q2 2023$11,3705,031
+11080.0%
0.00%
Q1 2023$045
-78.0%
0.00%
Q4 2022$02050.00%
Other shareholders
ETERNA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Cypress Point Wealth Management, LLC 94,375$320,8750.45%
Naviter Wealth, LLC 79,666$270,8640.10%
Sippican Capital Advisors 13,500$45,9000.04%
BALDWIN BROTHERS LLC/MA 9,470$32,1980.00%
Corient Private Wealth LLC 61,189$214,0710.00%
WELLS FARGO & COMPANY/MN 16$540.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 3,864$13,1380.00%
MONTAG A & ASSOCIATES INC 70$2380.00%
CITIGROUP INC 15$530.00%
View complete list of ETERNA THERAPEUTICS INC shareholders